The CCR4-NOT complex is a highly conserved, multifunctional machinery controlling mRNA metabolism. Its components have been implicated in several aspects of mRNA and protein expression, including transcription initiation, elongation, mRNA degradation, ubiquitination, and protein modification. In this review, we will focus on the role of the CCR4-NOT complex in mRNA degradation. The complex contains two types of deadenylase enzymes, one belonging to the DEDD-type family and one belonging to the EEP-type family, which shorten the poly(A) tails of mRNA. We will review the present state of structure-function analyses into the CCR4-NOT deadenylases and summarize current understanding of their roles in mRNA degradation. We will also review structural and functional work on the Tob/BTG family of proteins, which are known to interact with the CCR4-NOT complex and which have been reported to suppress deadenylase activity in vitro.
INTRODUCTION
The CCR4-NOT complex is highly and evolutionarily conserved among eukaryotes (Draper et al., 1995; Albert et al., 2000; Gavin et al., 2002) . It has been found in two predominant "supercomplex" forms in vivo, with approximate molecular weights of 0.9-1.2 MDa and 1.9-2.0 MDa in yeast. The smaller core complex in Saccharomyces cerevisiae Bai et al., 1999; Chen et al., 2001; Cui et al., 2008) was identified to contain five NOT proteins (Not1p to Not5p), Pop2p, Caf40p, Caf130p, Ccr4p and BTT1. A number of other proteins known to interact with Ccr4p, Pop2p or NOT proteins, such as Dhh1p Caf4p, Caf16p, Dbf2p and Mob1p, are believed to be part of the larger complex (Liu et al., 1997; Hata et al., 1998; Komarnitsky et al., 1998) . In mammals, including humans, their homologs also form a similar multisubunit complex which plays a significant role in the regulation of several cellular machines (Mahadevan and Struhl, 1990; Seufert and Jentsch, 1990; Collart and Struhl, 1993, 1994; Moqtaderi et al., 1996; Lee et al., 1998; Oberholzer and Collart, 1998; Badarinarayana et al., 2000; Tucker et al., 2001; Albert et al., 2002; Deluen et al., 2002; Lenssen et al., 2002; Maillet and Collart, 2002; Tucker et al., 2002; Viswanathan et al., 2003) .
Despite increasing understanding of the properties of the human CCR4-NOT complex, relatively little is known about its three-dimensional structure or its precise roles in the cell. The CCR4-NOT complex is implicated in a number of cellular functions, including several aspects of mRNA regulatory pathways Collart and Timmers, 2004) . The presence of human CNOT4 and yeast Not4p, which both harbour E3 ligase activity, places the CCR4-NOT complex in the protein ubiquitination/degradation pathways, although a recent analysis has suggested that the human CNOT4 does not stably interact with other human CCR4-NOT components and instead resides in a smaller~200 kDa complex outside the CCR4-NOT "supercomplex" (Lau et al., 2009) . Members of the CCR4-NOT complex are also associated with various functions in several species, either in the nucleus or the cytoplasm, including DNA repair and histone methylation in yeast, spindle positioning and regulation of microtubule length in Caenorhabditis elegans and spermatogenesis in mice.
Of the various functions with which the CCR4-NOT complex is associated, deadenylation has perhaps the greatest importance as it is crucial for gene expression and is involved in many biologic processes, from embryonic development to learning and memory (Goldstrohm and Wickens, 2008) . Regulation of mRNA stability, translation and localization determines how much protein is produced during mRNA translation. Newly synthesized mRNAs are accompanied by addition of a long poly(A) tail in the nucleus (Zhao et al., 1999) . Following export to the cytoplasm, poly(A) binding protein (PABP) binds to the tail, thus stabilizing the mRNA and facilitating translation. Changes in poly(A) tail length occur throughout the lifetime of an mRNA; deadenylase enzymes shorten the poly(A) tails of mRNAs and play a key role in translational repression. In eukaryotes, degradation of normal cytoplasmic mRNA involves two general pathways, both of which begin with deadenylation ( Fig. 1) . In one pathway, deadenylation is followed by a decapping enzyme complex, DCP1-DCP2, which hydrolyzes the 5¢ cap and exposes the mRNA body to 5¢-3¢ digestion by XRN1. In the second pathway, deadenylation leads to a 3¢-5¢ degradation of the RNA body by the exosome, which is a complex of 3¢-5¢ exonucleases. The two pathways are not mutually exclusive, although the relative contributions of each are unclear.
In this review, we will focus on the multi-subunit and multifunctional CCR4-NOT complex and its role in deadenylation and mRNA degradation. We aim to summarize the current state of structure-function studies pertaining to the deadenylase components.
STRUCTURE AND ASSEMBLY OF THE CCR4-NOT COMPLEX
From earlier studies on the yeast complex by mass spectrometry and co-immunoprecipitation, Liu and colleagues were able to identify the existence of the CCR4-NOT complex approximately 0.9-1.2 MDa in size . The complex was named CCR4-NOT for the association of five NOT proteins, Not1p to Not5p, with Ccr4p and Pop2p. The complex is centered on the scaffold protein Not1p, which contains no known functional motifs but possesses two strikingly Glu-rich regions, and which is essential for yeast viability. Not4p has been identified to possess a functional RING finger domain in its N-terminal by NMR (Hanzawa et al., 2001) , and its human homolog was subsequently confirmed to function as an E3 ligase by in vitro ubiquitination (Albert et al., 2002) . Not2p contains no known functional motifs but has two functional domains: a C-terminal region involved in CCR4-NOT function, and an N-terminal domain that interacts with the protein Ada2 (Benson et al., 1998) . Not3p and Not5p share similar N-terminal regions, but their respective functions remain unclear. The complex also contains two deadenylases (to be discussed in more detail below), as well as Caf40p and Caf130p with indeterminate function. A number of binding partners have been identified for the S. cerevisiae Figure 1 . The two mRNA degradation pathways. Following the shortening of poly(A) tails by deadenylase (deA) enzymes, the degradation of normal cytoplasmic mRNA involves two general pathways. In one pathway, deadenylation is followed by a decapping enzyme complex, DCP1-DCP2, which hydrolyzes the 5¢ cap and exposes the mRNA body to 5¢-3¢ digestion by XRN1. In the second pathway, deadenylation leads to the 3¢-5¢ degradation of the RNA body by the exosome. The cytoplasmic deadenylation step, in which the CCR4-NOT complex plays a major role, is highlighted. (Figure adapted from Goldstrohm and Wickens, 2008) . complex but will not be discussed further in this review (see (Collart, 2003) for more details).
In contrast to the yeast CCR4-NOT complex, which is well understood as a result of yeast genetics studies, the human complex has been less well studied until recently. In 2009, Lau and colleagues studied the composition of the human CCR4-NOT complex from stable HeLa cell derivatives expressing epitope-tagged CCR4-NOT subunits (Lau et al., 2009) . They determined the human complex to be generally similar to the yeast complex in composition, with CNOT1 as a scaffold and interacting with several CNOT proteins (CNOT2, CNOT7, CNOT8 and CNOT9). However, the authors also identified some differences between the yeast and human complexes, not least the presence of multiple deadenylases in human cells with different binding properties (to be discussed below). Furthermore, CNOT3 was not observed to bind directly to CNOT1 but instead binds to CNOT2 and may integrate into the complex via this interaction. Finally, CNOT4 is a true ortholog of yeast Not4p but, unlike its yeast counterpart, it appears not to be stably integrated into the human complex although it can interact with the scaffold protein CNOT1. A model can thus be proposed for the assembly of the human CCR4-NOT complex (Fig. 2) .
DEADENYLASES AND THEIR DIVERSITY
Deadenylases, which constantly erode the poly(A) tails of mRNA, are generally defined as magnesium-dependent exoribonucleases that recognize poly(A) tails as their main substrate and hydrolyze RNA in the 3¢-5¢ direction, resulting in release of 5¢-AMP. Following removal of the poly(A) tail, other enzymes then initiate the degradation of mRNA. Deadenylation can occur both in the nucleus and the cytoplasm. In the nucleus, deadenylation restricts newly added poly(A) tails of mRNA to their appropriate lengths, whereas extensive deadenylation of an mRNA in the cytoplasm initiates either degradation or repression. The deadenylation process can often be considered as a ratelimiting step for mRNA decay and translational silencing, and is therefore an ideal control point for both processes.
Biochemical and genetics analyses have greatly expanded the number of known deadenylases in recent years, and several putative deadenylases have been identified through bioinformatics but remain to be validated (see (Goldstrohm and Wickens, 2008 ) for a review). Deadenylases are currently categorized into two groups based on their nuclease domains. The first are the DEDD-type nucleases, so named after the conserved catalytic Asp and Glu residues in three exonuclease motifs. The major families of DEDD-type deadenylases include POP2, CAF1Z, poly(A)-specific ribonuclease (PARN) and PAN2. The second group is the exonuclease-endonuclease-phosphatase (EEP) family, which includes the families CCR4, Nocturnin, ANGEL and 2¢ phosphodiesterase (2¢PDE). The range of deadenylases varies among species, with members of the POP2, CCR4, PAN2 and ANGEL families present in all eukaryotes. Other deadenylases such as PAN and CAF1Z, which are both absent from Drosophila melanogaster, are less conserved. In addition to mRNA, poly(A) tails are also added to many nuclear, non-coding RNAs and are removed through deadenylation. The nuclear exosome complex for instance, has been strongly implicated in deadenylation; its RRP6 subunit is a DEDD-type nuclease and therefore the most likely deadenylating enzyme (Liu et al., 2006; Doma and Parker, 2007) .
THE CCR4-NOT DEADENYLASES
The S. cerevisiae CCR4-NOT complex encompasses two deadenylases, Ccr4p and Pop2p (Caf1p), both of which are involved in mRNA degradation although Pop2p is dispensable for the deadenylase activity of Ccr4p. Human orthologs for most of the CCR4-NOT components in yeast have been CNOT1 acts a scaffold to which the majority of the other CNOT proteins bind. CNOT3 is reported to have direct interaction with CNOT2 but not CNOT1. CNOT4 can bind CNOT1 is not stably associated with the CCR4-NOT complex. Human CCR4-NOT complexes are understood to only contain two deadenylases: one CCR4-type (either CNOT6 or CNOT6L) and one POP2-type (CNOT7 or CNOT8). Tob can associate with the CCR4-NOT complex via interaction with CNOT7. The CCR4-NOT proteins are labeled according to their name (i.e., CNOT1, CNOT2, etc.).
identified. Interestingly, two orthologs have been identified for each of the yeast deadenylases, Ccr4p and Pop2p, in the human CCR4-NOT complex. The two human orthologs of yeast Ccr4p are CNOT6 (hCcr4a) and CNOT6L (hCcr4b), while the two orthologs of Pop2p are CNOT7 (hCAF1) and CNOT8 (hPOP2/CALIF). CNOT7 and CNOT8 are important for cell proliferation and share high amino acid sequence similarity with partially overlapping function. CNOT6 and CNOT6L, on the other hand, have different functions. CNOT7 and CNOT8 have been characterized as belonging to the DEDD-type nucleases, while CNOT6 and CNOT6L belong to the EEP superfamily.
A recent report suggests that the human CCR4-NOT complex contains variable deadenylase subunits (Lau et al., 2009) . The authors showed the existence of distinct CCR4-NOT complexes containing either CNOT7 or CNOT8. The implication is that CNOT7 and CNOT8 may compete for the same binding site on the scaffold protein CNOT1. A separate study by Aslam and colleagues showed that both CNOT7 and CNOT8 are important for efficient cell proliferation in MCF7 breast cancer cells. Furthermore, using knockdown of CNOT7 and CNOT8 genes by siRNA transfection, the authors showed that CNOT7 and CNOT8 have partial redundancy in cell proliferation and can compensate for each other's function, which is to be expected given their high amino acid sequence similarity. Microarray analysis, however, indicated that CNOT7 and CNOT8 also appear to have unique functions, and both CNOT7 and CNOT8 are known to have different substrate specificities for their enzymatic activity.
Lau and colleagues further reported that CNOT6 and CNOT6L may also be mutually exclusive in CCR4-NOT complexes, as they found no unique peptides of CNOT6L in purified CNOT6-tagged complexes (Lau et al., 2009) . Earlier reports have suggested that CNOT6 and CNOT6L are functionally distinct: CNOT6L is required for cell proliferation via regulation of mRNA levels of the cell cycle inhibitor p27/ Kip1, whereas CNOT6 does not appear to be involved in cell proliferation (Morita et al., 2007) . Interestingly, both CNOT6 and CNOT6L interact more tightly with CNOT7 than with CNOT8. In effect, the results from Lau and colleagues support a model whereby CCR4-NOT complexes are distinct and only contain a single Ccr4p ortholog (CNOT6 or CNOT6L) and a single Pop2p ortholog (CNOT7 or CNOT8).
The CCR4-NOT deadenylases have been shown to be important for a number of specific biologic processes. CNOT7, for instance, is implicated in both fertility and physiology. In the first case, Cnot7-knockout mice are defective in spermatogenesis and males are sterile, although the mice remain viable (Berthet et al., 2004; Nakamura et al., 2004) . CNOT7 interacts with the retinoid X receptor beta and therefore might serve as a coregulator of Rxrb in testicular somatic cells (Nakamura et al., 2004) . In the second case, Cnot7-knockout mice exhibit increased bone mass as the result of enhanced bone formation, indicating that CNOT7 is an endogenous suppressor of bone mass (Washio-Oikawa et al., 2007) . Furthermore, cell growth in mammals can be reduced by overexpression of CNOT7 or reduction of CNOT6L expression (Bogdan et al., 1998; Morita et al., 2007) .
STRUCTURE AND ACTIVITY OF THE POP2 DEADENYLASES
The crystal structure of Pop2p was first determined from Saccharomyces cerevisiae in 2003 (Thore et al., 2003) , and later from Schizosaccharomyces pombe in 2009 (Andersen et al., 2009) (Fig. 3) . The overall structure of the S. cerevisiae Pop2p is kidney shaped with 13 α-helices and 6 β-strands (Fig. 3A) . Comparison with similar structures confirmed that Pop2p is a member of the DEDD-type nucleases with the common fold of the DnaQ subgroup. Despite low sequence similarity, Pop2p shares structural similarity with the e-subunit of DNA polymerase III and the exonuclease domain of DNA polymerase I. However, the S. cerevisiae Pop2p replaces the consensus DEDD nuclease motif with an SEDQ motif and so lacks several essential highly conserved catalytic residues, implying it may have lost its catalytic activity and that its role might be architectural. Pop2p was shown to have in vitro function as an active exonuclease on monotonous RNA sequences, with a slight preference for poly(A) RNA over poly (U) and poly(C). This lack of absolute specificity suggests that Pop2p may not bind RNA substrates in a specific manner, but may involve a substantial contribution of van der Waals interactions.
A structural and functional investigation of a homologous protein from Schizosaccharomyces pombe, or fission yeast, revealed more about the activity and selectivity of the deadenylase (Andersen et al., 2009) . Unlike the S. cerevisiae Pop2p, its S. pombe counterpart does feature an intact DEDD motif (Fig. 3C) . From the structure, two divalent metal ions (A and B) located in the active site were found to be essential for activity ( Fig. 3B and 3C) 
THE CCR4 DEADENYLASES
As a highly conserved member of the CCR4-NOT complex, yCcr4p is the major cytoplasmic deadenylase in yeast and acts as the main catalytic component (Chen et al., 2002) . Biochemical studies have placed the yeast Ccr4p in the EEP family, and it has been shown to contain three major functional domains (Draper et al., 1994) . The N-terminal region is rich in glutamines and asparagines and is believed to have an activation domain that may interact with the transcriptional machinery. The central region contains several tandem copies of a leucine-rich-repeat (LRR) domain (Malvar et al., 1992) , which has been shown to interact with yCaf1p (Draper et al., 1995) , with other putative components of the core CCR4-NOT complex (Liu et al., 2001) , and with potential binding ligands of the whole complex. This domain is thus considered to be the link that connects yCcr4p to the reminder of the complex (Draper et al., 1994; Liu et al., 1998 ) and other ligands. The LRR domain distinguishes all Ccr4p orthologs from other EEP family members and CCR4-like proteins (Dupressoir et al., 2001; Chen et al., 2002) . The C-terminal region contains a deadenylase domain characteristic of the EEP superfamily with conserved catalytic Asp and His residues in the activation domain. The human orthologs, CNOT6 and CNOT6L, share the LRR domain and nuclease domain with yCcr4p, but lack the N-terminal Glu/Asp-rich region.
At the time of writing, no three-dimensional structure of a CCR4-type deadenylase has been determined. Nevertheless, within the EEP family, the C-terminal region of yCcr4p exhibits significant homology to the exonuclease III group of proteins, also known as apurinic (AP) endonucleases, which are critical for maintaining genome integrity against the spontaneous production of abasic sites (Chen et al., 2002) . Three representative AP endonucleases in this family are the exonuclease III (Exo III) from Escherichia coli, human APE1 (HAP1), and APN2 from S. cerevisiae (Chen et al., 2002) . This family of Mg 2+ -dependent endonucleases is also homologous to inositol polyphosphate-5¢-phosphatases and sphingomyelinases (Dlakić, 2000; Whisstock et al., 2000) . From biochemical analysis, Chen and colleagues confirmed that yCcr4 displays 3¢-5¢ exoribonuclease activity with strict poly(A) substrate specificity and a preference toward substrates with at least two As at the 3¢ end (Chen et al., 2002) . 
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The structural basis for deadenylation by the CCR4-NOT complex
Protein & Cell THE TOB/BTG ANTIPROLIFERATIVE PROTEINS
The Tob/BTG family are antiproliferative proteins consisting of Tob, Tob2, BTG1, BTG2/Tis21/PC3, PC3B and BTG3/ANA in mammalian cells; AF177464 in Drosophila, and FOG-3 in Caenorhabiditis elegans. Tob/BTG proteins gain their antiproliferative activities due to their association with target proteins in cells, such as the association of Tob with the SMAD family to act as a negative regulator of SMAD signaling. Both Tob and BTG2 have been shown to interact with the CCR4-NOT complex via CNOT7 (Rouault et al., 1998; Prévôt et al., 2001) , and BTG2 works as a co-activator of ERα-mediated transcription via a CCR4-like complex (Morel et al., 2003) . To date, a number of crystal structures of Tob/BTG family members have been determined: human Tob1 (PDB ID: 2Z15), human BTG2 and mouse TIS21. A three-dimensional structure of the human Tob/CNOT7 complex has also been reported and will be discussed in further detail below. Tob, BTG2 and TIS21 share a similar structure comprised of five α-helices and four β-strands that form two anti-parallel β-sheets. The N-terminal leads immediately into a bundle of three α-helices, followed by four β-strands with two small α-helices inserted between strands β1 and β2. The structure of human BTG2, which shares 40% sequence identity with Tob, shows three highly conserved domains among the Tob/BTG2 family (Fig. 4A) (Guéhenneux et al., 1997; Yang et al., 2008) . Box A, also known as GR (for growth regulatory), is composed of strand β1, the short helix α3, part of the α2 helix and a connecting loop between them. Two anti-parallel β-strands (β2 and β3) form Box B, which is important for binding to a number of molecular targets including CNOT7. Box C is composed of strand β4 and the extended C-terminal loop. Helix α1, part of the α2 helix and the connecting loop between them constitute the putative HOXB9 interaction region. As BTG2 can associate with various molecular targets via different regions (Rouault et al., 1998; Prévôt et al., 2000; Berthet et al., 2002) , the BTG2 structure showed that the relevant interfaces are located on different surfaces of BTG2 and may not interfere with each other, raising the possibility that BTG2 may be able to bind two or more molecular targets simultaneously in order to fulfil different regulatory requirements. Two LXXLL motifs, also known as the nuclear receptor box (NR box), are located on helices α2 and α5, respectively. Interestingly, these two motifs are located on opposing faces of BTG2 and provide a hydrophilic surface, which might facilitate contact with nuclear receptors, while the hydrophobic residues are buried inside the core of the protein.
THE INTERACTION OF TOB/BTG ANTIPROLIFERATIVE PROTEINS WITH CNOT7
As mentioned above, accumulating evidence supports that the Tob/BTG family of proteins are common binding partners of CNOT7 in the CCR4-NOT complex. In 2009, Horiuchi and colleagues reported the crystal structure of the Tob-CNOT7 complex, thus demonstrating the mode of interaction between the two proteins, and suggested a mechanism for the antiproliferative activity of the complex (Horiuchi et al., 2009) . The interaction of Tob with CNOT7 is largely hydrophobic and mediated by the conserved Box A and Box B regions (Fig. 4B) . The presence of Tob had no appreciable effect on the activity of CNOT7. Based on their structure and functional analysis, Horiuchi and colleagues then proposed a hypothesis in which Tob recruits a PABP-mRNA complex to the CCR4-NOT complex via interaction with CNOT7, suggesting that CNOT7 functions as a bridge between Tob and the CCR4-NOT complex, rather than as a deadenylase. In their model, recruitment of the PABP-mRNA complex would cause translation to be interrupted by rapid degradation of the poly (A) tail, presumably by CNOT6 or CNOT6L, followed by repression of cell growth.
Analysis of human BTG2 by Yang and colleagues showed that it shares a significantly conserved CNOT7 binding interface with Tob (Yang et al., 2008) . Moreover, functional analysis indicated that BTG2 suppresses CNOT7 deadenylase activity in vitro via direct interaction. However, structural analysis clearly showed that the binding interface of BTG2 and CNOT7 is not close to the active site of CNOT7, suggesting that binding of BTG2 may induce local conformational changes that influence the activity of CNOT7 or even distort the active site.
BTG2 was recently shown to be a general activator of mRNA degradation, for which the deadenylase activities of both CNOT7 and CCR4 are involved (Mauxion et al., 2008 ). The precise mechanism by which BTG2 enhances mRNA deadenylation remains to be determined, however, as BTG2 was unable to trigger the deadenylase activity of CNOT7 in vitro (Mauxion et al., 2008) . In contrast, BTG2 was found to suppress the deadenylase activity of CAF1 in vitro (Yang et al., 2008) , while Tob has also been shown to interact with the CCR4-NOT complex and inhibit its deadenylase activity in vitro (Miyasaka et al., 2008) . The Tob/BTG family proteins therefore inhibit deadenylase activity associated with the CNOT7-containing CCR4-NOT complex, at least in vitro. CNOT7 alone is apparently not the decisive factor in mRNA deadenylation, and alternative pathways of cellular mRNA decay may come into play when its deadenylase activity is suppressed by BTG2. One possibility might be that CNOT7 may release its mRNA substrate and transfer it to other deadenylases such as PAN2-PAN3, although further studies are required to help understand the contradictory results for the roles of Tob and BTG2 on mRNA decay in vivo and in vitro.
UNDERSTANDING DEADENYLATION AND MRNA DEGRADATION
The presence of two deadenlyases in the CCR4-NOT complex remains puzzling and their mutual roles in mediating mRNA degradation is still unclear. Understanding the mutual functions of these two deadenylases, one belonging to the DEDD-type family and one to the EEP-type family, has been hampered in part by the lack of a three-dimensional structure for either yeast Ccr4p or its human orthologs. Data for the yeast CCR4-NOT complex has suggested that most of the nuclease activity is provided by Ccr4p (Chen et al., 2002; Tucker et al., 2002) , and it may be the case that the role of Pop2p is to target the yeast CCR4-NOT complex to the poly (A) tail for further degradation by Ccr4p. The situation in the human CCR4-NOT complex is further complicated by the existence of two orthologs each for Pop2p and Ccr4p. The observation of four different complexes consisting of CNOT6-CNOT7, CNOT6L-CNOT7, CNOT6-CNOT8 or CNOT6L-CNOT8 heterodimers may provide an effective mechanism for the differential regulation of mRNA degradation (Lau et al., 2009 ). Further complexity is added by the association of the deadenylase heterodimers, consisting of one CCR4-type and one POP2-type protein, with other CNOT proteins in large multi-subunit "supercomplexes" with molecular weights ranging up to 2.0 MDa. It is not clear at this point what role, if any, the other CNOT proteins play in deadenylation.
In their study on the concerted action of poly(A) nucleases, Yamashita and colleagues proposed that cytoplasmic deadenylation in mammalian cells is biphasic in nature (Yamashita et al., 2005) . The first phase involves synchronous and stepwise shortening of the poly(A) tail to~110 nt. In the second phase, the mRNAs become more heterogeneous in the lengths of their poly(A) tails, ranging from~20 nt to~110 nt. The second phase is crucial to trigger decay of the mRNA body. Several observations support the hypothesis that biphasic deadenylation is the result of the sequential action of PAN2-PAN3 and CCR4-POP2 complexes (Fig. 5) , with PAN2-PAN3 dominating the first phase and CCR4-POP2 the second phase. For instance, the poly(A) binding protein (PABP) is reported to stimulate the PAN2-PAN3 complex but inhibits the CCR4-POP2 nuclease and DCP1-DCP2 decapping activities. Furthermore, changes in the activity of CCR4 affect the second phase of deadenylation, suggesting that the two phases are linked.
In summary, deadenylation is the first step in mRNA decay, and as such is an important biologic process with a number of important functions in the cell. The CCR4-NOT complex contains two deadenylases, yet efforts to understand their respective structures and activities have only scratched the surface. A number of important questions remain to be answered, such as how CCR4 and POP2 deadenylases cooperate to perform their functions. What role does the large CCR4-NOT complex play in the deadenylation process, and what are the factors that determine how mRNAs are regulated by specific deadenylases? Another important question to consider is how deadenylation is regulated. To date, a number of specific regulators that control deadenylation by recruiting CCR4-POP2 complexes have been reported, including PABP, PUF, CPEB, TTP and microRNAs (miRNAs). These latter miRNAs can elicit multifunctional control by repressing mRNA translation, enhancing mRNA decay and causing deadenylation, and are known to enhance mRNA deadenylation through the CCR4-NOT complex. PABP, for instance, is known to inhibit the deadenylase activity of the CCR4-NOT complex but not the PAN2-PAN3 deadenylase. It is evident that further structural and functional work is required to get to the heart of mRNA degradation, and to elucidate the roles of the multifunctional CCR4-NOT "supercomplex" in mRNA decay and beyond.
